Related references
Note: Only part of the references are listed.NCI-60 Combination Screening Matrix of Approved Anticancer Drugs
S. Holbeck et al.
EUROPEAN JOURNAL OF CANCER (2012)
Resveratrol in human cancer chemoprevention - Choosing the right' dose
Edwina Scott et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2012)
trans-Resveratrol in Nutraceuticals: Issues in Retail Quality and Effectiveness
Damiano Rossi et al.
MOLECULES (2012)
Two Hundred Years of Cancer Research
Vincent T. DeVita et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
What Does It Take to Synergistically Combine Sub-Potent Natural Products into Drug-Level Potent Combinations?
Chu Qin et al.
PLOS ONE (2012)
A High-Content Biosensor-Based Screen Identifies Cell-Permeable Activators and Inhibitors of EGFR Function: Implications in Drug Discovery
Christophe Antczak et al.
JOURNAL OF BIOMOLECULAR SCREENING (2012)
Managing drug resistance in cancer: lessons from HIV therapy
Christoph Bock et al.
NATURE REVIEWS CANCER (2012)
The anti-tumor effect of resveratrol alone or in combination with immunotherapy in a neuroblastoma model
Brenda L. Soto et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Intra-arterial and Oral Digoxin Therapy for Retinoblastoma
Mrinali Patel et al.
OPHTHALMIC GENETICS (2011)
What Is New for an Old Molecule? Systematic Review and Recommendations on the Use of Resveratrol
Ole Vang et al.
PLOS ONE (2011)
Strategies to Manage Retinoblastoma in Developing Countries
Guillermo L. Chantada et al.
PEDIATRIC BLOOD & CANCER (2011)
Resveratrol: Challenges in Translation to the Clinic - A Critical Discussion
Lalita Subramanian et al.
CLINICAL CANCER RESEARCH (2010)
Resveratrol and derivatives for the prevention and treatment of cancer
Simone Fulda
DRUG DISCOVERY TODAY (2010)
Resveratrol confers resistance against taxol via induction of cell cycle arrest in human cancer cell lines
Qi-Qi Mao et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2010)
Utilizing targeted cancer therapeutic agents in combination: novel approaches and urgent requirements
Shivanni Kummar et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Targeting the cancer kinome through polypharmacology
Zachary A. Knight et al.
NATURE REVIEWS CANCER (2010)
Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms
Mohammad Athar et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2009)
Methionine depletion with recombinant methioninase: In vitro and in vivo efficacy against neuroblastoma and its synergism with chemotherapeutic drugs
Jian Hu et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Drug Discovery and Natural Products: End of an Era or an Endless Frontier?
Jesse W. -H. Li et al.
SCIENCE (2009)
Revisiting Old Drugs as Novel Agents for Retinoblastoma: In Vitro and In Vivo Antitumor Activity of Cardenolides
Christophe Antczak et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
Mechanisms of cardiac dysfunction associated with tyrosine kinase inhibitor cancer therapeutics
Ming Hui Chen et al.
CIRCULATION (2008)
A high density assay format for the detection of novel cytotoxic agents in large chemical libraries
David Shum et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2008)
Resveratrol inhibits uveal melanoma tumor growth via early mitochondrial dysfunction
Paul R. van Ginkel et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)
High-throughput identification of inhibitors of human mitochondrial peptide deformylase
Christophe Antczak et al.
JOURNAL OF BIOMOLECULAR SCREENING (2007)
Mitochondria as the primary target of resveratrol-induced apoptosis in human retinoblastoma cells
Dhruv Sareen et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2006)
Aurora kinase inhibitor ZM447439 blocks chromosome-induced spindle assembly, the completion of chromosome condensation, and the establishment of the spindle integrity checkpoint in Xenopus egg extracts
BB Gadea et al.
MOLECULAR BIOLOGY OF THE CELL (2005)
Resveratrol inhibits drug-induced apoptosis in human leukemia cells by creating an intracellular milieu nonpermissive for death execution
KA Ahmad et al.
CANCER RESEARCH (2004)
Resveratrol inhibits TCDD-induced expression of CYP1A1 and CYP1B1 and catechol estrogen-mediated oxidative DNA damage in cultured human mammary epithelial cells
ZH Chen et al.
CARCINOGENESIS (2004)
Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification
ME Gorre et al.
SCIENCE (2001)
Share Paper
